These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23817916)

  • 1. The association of plasma lactate with incident cardiovascular outcomes: the ARIC Study.
    Matsushita K; Williams EK; Mongraw-Chaffin ML; Coresh J; Schmidt MI; Brancati FL; Hoogeveen RC; Ballantyne CM; Young JH
    Am J Epidemiol; 2013 Aug; 178(3):401-9. PubMed ID: 23817916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
    Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
    Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
    J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.
    Selvin E; Rawlings A; Lutsey P; Maruthur N; Pankow JS; Steffes M; Coresh J
    Diabetes; 2016 Jan; 65(1):201-8. PubMed ID: 26395741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study.
    Juraschek SP; Selvin E; Miller ER; Brancati FL; Young JH
    Ann Epidemiol; 2013 Dec; 23(12):791-796.e4. PubMed ID: 24176820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Agarwala A; Pokharel Y; Saeed A; Sun W; Virani SS; Nambi V; Ndumele C; Shahar E; Heiss G; Boerwinkle E; Konety S; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2017 Jul; 262():131-137. PubMed ID: 28554015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure.
    Parikh RR; Folsom AR; Misialek JR; Rosamond WD; Chang PP; Tang W; Cushman M
    Thromb Res; 2019 Oct; 182():89-94. PubMed ID: 31473403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
    Dubin R; Li Y; Ix JH; Shlipak MG; Whooley M; Peralta CA
    Am Heart J; 2012 Feb; 163(2):274-9. PubMed ID: 22305847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.
    Lutsey PL; Alonso A; Selvin E; Pankow JS; Michos ED; Agarwal SK; Loehr LR; Eckfeldt JH; Coresh J
    J Am Heart Assoc; 2014 Jun; 3(3):e000936. PubMed ID: 24922628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
    Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
    JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining Lung Function and Cardiovascular Risk: The ARIC Study.
    Silvestre OM; Nadruz W; Querejeta Roca G; Claggett B; Solomon SD; Mirabelli MC; London SJ; Loehr LR; Shah AM
    J Am Coll Cardiol; 2018 Sep; 72(10):1109-1122. PubMed ID: 30165982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study.
    Imamura T; Doi Y; Ninomiya T; Hata J; Nagata M; Ikeda F; Mukai N; Hirakawa Y; Yoshida D; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2014 Apr; 233(2):343-348. PubMed ID: 24530960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and Subtypes of Incident Cardiovascular Disease.
    Ndumele CE; Matsushita K; Lazo M; Bello N; Blumenthal RS; Gerstenblith G; Nambi V; Ballantyne CM; Solomon SD; Selvin E; Folsom AR; Coresh J
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27468925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.
    Ahmad FS; Ning H; Rich JD; Yancy CW; Lloyd-Jones DM; Wilkins JT
    JACC Heart Fail; 2016 Dec; 4(12):911-919. PubMed ID: 27908389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
    Oyenuga AO; Couper D; Matsushita K; Boerwinkle E; Folsom AR
    PLoS One; 2018; 13(10):e0205310. PubMed ID: 30300402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study.
    Srinath R; Hill Golden S; Carson KA; Dobs A
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1602-8. PubMed ID: 25584720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.
    Aguilar D; Sun C; Hoogeveen RC; Nambi V; Selvin E; Matsushita K; Saeed A; McEvoy JW; Shah AM; Solomon SD; Boerwinkle E; Ballantyne CM
    J Am Heart Assoc; 2020 Jul; 9(13):e015405. PubMed ID: 32573308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study.
    Chien KL; Hsu HC; Sung FC; Su TC; Chen MF; Lee YT
    Atherosclerosis; 2005 Nov; 183(1):147-55. PubMed ID: 16154134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.